Virtual reality to reduce discomfort during pacemaker and defibrillator implantation
Official title: Acute Clinical Outcomes Following the Implementation of Virtual Reality (VR) in the Electrophysiology Laboratory
Run by University of Calabria · NCT07009951 · Data updated 2026-11-12
We will test whether using virtual reality during pacemaker or implantable defibrillator implantation helps lower pain and anxiety for adult patients compared with standard sedation alone.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Calabria Academic / other |
| Locations | 1 site (Cosenza) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | October 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT07009951 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult patients (≥18 years) scheduled for pacemaker or implantable cardioverter-defibrillator implantation who can provide informed consent and use a VR headset are ideal candidates.
✕Probably not a fit
Patients with severe cognitive, psychiatric, visual, auditory, or vestibular disorders or those who cannot correctly position a VR headset are unlikely to benefit from the VR intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center, randomized study at Annunziata Hospital that assigns adults undergoing pacemaker or ICD implantation to either standard sedation alone or standard sedation plus a VR headset for distraction. Pain will be measured with a numeric rating scale and vital signs will be monitored throughout the procedure, while patient satisfaction and adverse events are recorded. The trial includes modern device types such as leadless pacemakers and subcutaneous ICDs and also explores whether VR can support same-day discharge after minimally invasive procedures. Outcomes will compare pain levels, sedation needs, physiological stability, and safety between the two groups.
Why it matters
Potential benefit: If successful, adding VR could reduce procedural pain and anxiety, reduce sedation needs, and improve recovery and readiness for same-day discharge.
How similar studies have gone: Previous randomized and nonrandomized studies in other procedural settings have shown that VR can reduce pain and anxiety, but applying VR specifically to pacemaker or ICD implantation is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years. * Patients who are candidates for pacemaker (PM) or implantable cardioverter-defibrillator (ICD) implantation, including new devices such as leadless PM and subcutaneous ICD (S-ICD). * Ability to provide written informed consent. * Ability to understand the use of the VR headset and express a pain score using the NRS scale. Exclusion Criteria: * Severe cognitive, psychiatric or neurological disorders that impair understanding or collaboration in the study. * Visual and/or auditory and inner ear disorders or severe vertigo that could be aggravated by VR. * Allergies or known adverse reactions to standard sedative therapies provided for in the protocol (e.g. midazolam) if essential for the procedure. * Inability to correctly position the VR headset (e.g. severe facial deformities, recent trauma to the craniofacial area).
Where it's running
-
"Annunziata" Hospital
Cosenza, Italy Recruiting
Study contacts
- Study coordinator: Antonio Curcio, Prof.
- Email: antonio.curcio.cardio@unical.it
- Phone: +390984681889
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SAM aluminium splint for suspected wrist fractures
This study will see if adding a SAM aluminium splint to usual care reduces pain for people with suspected wrist fractures who come to the emergency department.
-
Combined acupressure to reduce post-thoracotomy pain and improve lung volume
This trial will try combined acupressure on patients after thoracotomy to see if it reduces postoperative pain and helps restore lung volume.
-
Phase 1 testing of SBS-147 in healthy adults
This study will test if SBS-147 is safe and how healthy adults' bodies handle single or repeated doses compared with a placebo.
-
Butyrate and Taurine for Chronic Postoperative Pain in Adults after Cardiac Surgery
This study tests whether taking taurine and butyrate daily can reduce long-lasting pain after cardiac surgery in adults.
-
Perioperative IV nimodipine for people undergoing open colectomy for bowel cancer
This trial tests whether giving intravenous nimodipine around the time of open colectomy can reduce opioid use, lower pain, and speed early bowel recovery for people having surgery for bowel cancer.
-
Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis
We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.